# Grupo Médico Ángeles (Guatemala)

Source: https://onco.cc/institutions/grupo-medico-angeles-guatemala/  
OnCo record `grupo-medico-angeles-guatemala` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A group of oncologists in Guatemala City that has been a site for many international cancer drug trials, in breast, stomach and lung cancer among others.

## Summary

Grupo Médico Ángeles is listed on ClinicalTrials.gov as a Guatemala City site of trials the corpus holds, including ALEX, APHINITY, CLEOPATRA, GATSBY, KATHERINE, IMpassion130, OAK, LIDERA and HERIZON-GEA-01. Its CRECE website names Hugo Castro, a medical oncologist trained at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico and an associate professor of the Guatemala National Cancer Institute, as medical director, with research interests in the natural history of breast cancer, and describes him as a co-investigator in multicentre trials in breast, lung and gastric cancer. The coordinates are an approximate Guatemala City point.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: Grupo Angeles; Grupo Medico Angeles; Angeles Medical Group, Guatemala
- City: Guatemala City, GT
- Type: hospital

## Sources

- CRECE: Grupo Ángeles (medical directors): https://crece.xplorandoguatemala.com/notas/grupo-ngeles
- ClinicalTrials.gov NCT01358877 (site list): https://clinicaltrials.gov/study/NCT01358877
- ClinicalTrials.gov NCT04961996 (site list): https://clinicaltrials.gov/study/NCT04961996
- ClinicalTrials.gov NCT05152147 (site list): https://clinicaltrials.gov/study/NCT05152147

## Connected records

- institutions: [Instituto de Cancerología y Hospital Dr. Bernardo del Valle S. (INCAN)](https://onco.cc/institutions/incan-guatemala/), [Instituto Guatemalteco de Seguridad Social (IGSS)](https://onco.cc/institutions/igss-guatemala/)
- trials: [A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies](https://onco.cc/trials/nct00781612/), [A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study](https://onco.cc/trials/nct03768063/), [A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)](https://onco.cc/trials/nct06065748/), [ALEX](https://onco.cc/trials/alex/), [APHINITY](https://onco.cc/trials/aphinity/), [CLEOPATRA](https://onco.cc/trials/cleopatra/), [GATSBY](https://onco.cc/trials/gatsby/), [HERIZON-GEA-01](https://onco.cc/trials/herizon-gea-01/), [IMpassion130](https://onco.cc/trials/impassion130/), [KATHERINE](https://onco.cc/trials/katherine/), [lidERA](https://onco.cc/trials/lidera/), [OAK](https://onco.cc/trials/oak/)

---
JSON: https://onco.cc/api/v1/entities/grupo-medico-angeles-guatemala.json